Low-dose radiotherapy concurrent with atezolizumab and chemotherapy as first-line treatment for extensive-stage small-cell lung cancer: 3-year follow-up of a multicenter, single-arm, phase 2 trial (MATCH).Zhou L, Sun J, Xie C, et al. Int J Radiat Oncol Biol Phys. 2025 Jul 1:S0360-3016(25)04508-0. do…